Clinical Trial Update: Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) [Phase 1]

View source ↗

Summary

Phase 1 study Beamion LUNG-1 evaluating multiple doses of Zongertinib in adults with advanced cancers harboring HER2 gene alterations, including non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Zongertinib (Zongertinib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasm Metastasis, Non-Small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING